Compare BSX & MDLZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BSX | MDLZ |
|---|---|---|
| Founded | 1979 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.4B | 79.3B |
| IPO Year | 2010 | 2001 |
| Metric | BSX | MDLZ |
|---|---|---|
| Price | $48.80 | $61.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 22 | 20 |
| Target Price | ★ $93.18 | $66.95 |
| AVG Volume (30 Days) | ★ 20.8M | 6.4M |
| Earning Date | 04-22-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.28% |
| EPS Growth | ★ 55.20 | N/A |
| EPS | ★ 0.90 | 0.44 |
| Revenue | $9,076,000,000.00 | ★ $38,537,000,000.00 |
| Revenue This Year | $11.85 | $4.83 |
| Revenue Next Year | $10.16 | $3.10 |
| P/E Ratio | ★ $54.16 | $139.93 |
| Revenue Growth | ★ 12.49 | 5.75 |
| 52 Week Low | $47.17 | $51.20 |
| 52 Week High | $109.50 | $71.15 |
| Indicator | BSX | MDLZ |
|---|---|---|
| Relative Strength Index (RSI) | 31.95 | 56.41 |
| Support Level | N/A | $60.25 |
| Resistance Level | $58.35 | $62.60 |
| Average True Range (ATR) | 1.48 | 1.19 |
| MACD | -0.16 | -0.11 |
| Stochastic Oscillator | 13.35 | 60.19 |
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
Mondelez has operated independently since its split from the former Kraft Foods North American grocery business in October 2012. The firm is a leading player in the global snack enclave with a presence in the biscuit (48% of sales as of the end of fiscal 2025), chocolate (33%), gum/candy (10%), beverage (3%), and cheese and grocery (6%) aisles. Mondelez's portfolio includes well-known brands like Oreo, Chips Ahoy, Halls, and Cadbury. The firm derives around one-third of its revenue from developing markets, around 40% from Europe, and more than one-fourth from North America.